论文信息 - Randomized phase III study comparing conventional-dose doxorubicin plus ifosfamide versus high-dose doxorubicin plus ifosfamide plus recombinant human granulocyte-macrophage colony-stimulating factor in advanced soft tissue sarcomas: A trial of the European Organization for Research and Treatment of - 字舞流文

Randomized phase III study comparing conventional-dose doxorubicin plus ifosfamide versus high-dose doxorubicin plus ifosfamide plus recombinant human granulocyte-macrophage colony-stimulating factor in advanced soft tissue sarcomas: A trial of the European Organization for Research and Treatment of

J. Blay | S. Rodenhuis | M. van Glabbeke | H. Keizer | D. Crowther | J. Verweij | M. Glabbeke | A. Cesne | A. Le Cesne | A. V. van Oosterom | I. Judson | T. Tursz | C. Hermans | J. Blay | J. Frisch | Q. V. Hoesel | Q. V. van Hoesel | A. Oosterom | M. V. Van Glabbeke | Q. van Hoesel | Derek Crowther | I. Judson | Cédric Hermans | Thomas Tursz